AVH represents the CHESS Depositary Interests of AVITA Medical traded on the Australian Securities Exchange, mirroring the underlying value of its NASDAQ-listed counterpart. Evaluated as an investment vehicle, it shares the same fundamental thesis: high upside potential driven by innovative regenerative therapies balanced against the execution risks typical of commercial-stage medical device firms scaling toward profitability.